With your support, we have been able to fund outstanding research, leading toward cures and improved quality of life for children with cancer. Browse through more than 1,000 funded projects below.
Use the search tool to refine your results. You can also click on a heading to sort by project title, institution name, or year the grant was awarded. Click on the project title to read more information.
You can learn about ALSF's grant review process here.
ALSF Funded Research Projects
|Project Title||Institution / Principal Investigator(s)||Grant Type||Year||State|
|Integrative Genomic and Immunogenomic Analysis of Neuroblastoma||University of California at Santa Cruz / David Haussler, PhD||Innovation Grants||2015||California|
|High-Throughput Gene-Editing via Microfluidic Cell Deformability to Enable Off-the-Shelf Allogeneic Cellular Immunotherapies||University of California, Los Angeles / Steven Jonas, MD/PhD||Young Investigator Grants||2017||California|
|Maternal Comorbidities, Pharmaceutical Use and Childhood Cancers: A Record Linkage Study in Taiwan||University of California, Los Angeles / Julia Heck, PhD||Epidemiology Grants||2017||California|
|Single-cell Profiling of Pediatric Bone Sarcomas||University of California, Los Angeles / Alice Soragni, PhD||Single-cell Pediatric Cancer Atlas Grant||2019||California|
|Pain and Symptom Experiences in Children with Cancer||University of California, Los Angeles / Eufemia Jacob, PhD, RN||Nurse Researcher Grants||2007||California|
|Develop a Therapeutic Vaccine Approach by Removing Viral Immune Evasion||University of California, Los Angeles / Ren Sun, PhD||Springboard Grants||2013||California|
|Engineering the Lymph Node Environment with Therapeutic Vaccine Depots to Combat Neuroblastoma||University of Maryland, College Park / Christopher Jewell, PhD||'A' Award Grants||2013||Maryland|
|Circadian Rhythms, Fatigue and Bright Light Therapy in Adolescent Cancer Survivors||University of Maryland, College Park / Valerie E. Rogers, PhD||Nurse Researcher Grants||2015||Maryland|
|Preclinical Development of Atr Inhibitor VE-822, Delivered Systemically in Nanoparticles, for Medulloblastoma Therapy||University of North Carolina / Timothy Gershon, MD, PhD||Innovation Grants||2015||North Carolina|
|Targeting Chondroitin Sulphate Proteoglycan 4 (CSPG4) in Glioblastoma||University of North Carolina / Gianpietro Dotti, MD & Barbara Savoldo, MD/PhD||Reach Grants||2017||North Carolina|